Published in Gene Therapy Weekly, November 4th, 2004
Study findings were reported at the 26th Annual Meeting of the American Society for Bone Mineral Research (ASBMR).
"These findings are important because they show that Boniva has potential for once-monthly oral dosing, which may provide a more convenient treatment option for many women with postmenopausal osteoporosis," said lead...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.